New Funding Opportunity from CIHR
CIHR’s Health Effects of Vaping Catalyst Grant funding opportunity will support projects relevant to the following research areas:
- Youth vaping of nicotine, cannabinoid extracts, THC, and other compounds
- Short and/or long-term health effects of vaping (including lung injury in youth and/or adults)
- Behaviours and associated health and social impacts of vaping product use (youth and/or adults)
- Mental health, addiction and dependence in the context of vaping (youth and/or adults)
- Vaping policy issues related to youth and/or adults
- Vaping and oral health (youth and/or adults)
- Other areas related to the health consequences of vaping in youth and/or adults
Sex and/or gender issues are an important component of this research initiative. Studies using preclinical models, mechanistic, human and/or population-based approaches are eligible for this funding opportunity. Research projects exploring the use of vaping as a smoking cessation tool or as a harm reduction strategy, however, are not eligible.
Registration deadline is March 25, 2020. For more information, click here.
Accelerating the Commercialization of Cancer Research Results
The Canadian Cancer Society (CCS) and the Creative Destruction Lab (CDL) have launched a new world-class accelerator program for entrepreneurs and researchers developing innovations to improve the cancer experience globally and throughout the cancer care continuum. This program will educate, coach, finance and inspire seed-stage oncology-focused companies by pairing them with mentors, industry leaders and subject matter experts. Over 9 months and 5 sessions, accepted startups will be supporte... Read More »
New Members Join the Alliance
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
... Read More »
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
... Read More »